US2433244A - Enteric coating - Google Patents
Enteric coating Download PDFInfo
- Publication number
- US2433244A US2433244A US551631A US55163144A US2433244A US 2433244 A US2433244 A US 2433244A US 551631 A US551631 A US 551631A US 55163144 A US55163144 A US 55163144A US 2433244 A US2433244 A US 2433244A
- Authority
- US
- United States
- Prior art keywords
- cellulose
- coating
- shellac
- enteric
- tablets
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 239000002702 enteric coating Substances 0.000 title description 17
- 238000009505 enteric coating Methods 0.000 title description 17
- 229920002678 cellulose Polymers 0.000 description 28
- 229920001800 Shellac Polymers 0.000 description 25
- 238000000576 coating method Methods 0.000 description 25
- 239000004208 shellac Substances 0.000 description 25
- ZLGIYFNHBLSMPS-ATJNOEHPSA-N shellac Chemical compound OCCCCCC(O)C(O)CCCCCCCC(O)=O.C1C23[C@H](C(O)=O)CCC2[C@](C)(CO)[C@@H]1C(C(O)=O)=C[C@@H]3O ZLGIYFNHBLSMPS-ATJNOEHPSA-N 0.000 description 25
- 229940113147 shellac Drugs 0.000 description 25
- 235000013874 shellac Nutrition 0.000 description 25
- 150000002148 esters Chemical class 0.000 description 21
- 239000003826 tablet Substances 0.000 description 20
- 239000011248 coating agent Substances 0.000 description 19
- 239000007788 liquid Substances 0.000 description 19
- 239000001913 cellulose Substances 0.000 description 16
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 15
- 239000002904 solvent Substances 0.000 description 13
- 210000002784 stomach Anatomy 0.000 description 12
- 239000000126 substance Substances 0.000 description 12
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 11
- 238000002360 preparation method Methods 0.000 description 10
- 239000003814 drug Substances 0.000 description 9
- 210000000936 intestine Anatomy 0.000 description 9
- 229920000623 Cellulose acetate phthalate Polymers 0.000 description 8
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 8
- 229940081734 cellulose acetate phthalate Drugs 0.000 description 8
- 238000001035 drying Methods 0.000 description 8
- 239000003960 organic solvent Substances 0.000 description 8
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 8
- 239000002253 acid Substances 0.000 description 7
- 239000000203 mixture Substances 0.000 description 7
- ZWEHNKRNPOVVGH-UHFFFAOYSA-N 2-Butanone Chemical compound CCC(C)=O ZWEHNKRNPOVVGH-UHFFFAOYSA-N 0.000 description 6
- 230000037406 food intake Effects 0.000 description 6
- 239000011347 resin Substances 0.000 description 6
- 229920005989 resin Polymers 0.000 description 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 5
- GAMPNQJDUFQVQO-UHFFFAOYSA-N acetic acid;phthalic acid Chemical compound CC(O)=O.OC(=O)C1=CC=CC=C1C(O)=O GAMPNQJDUFQVQO-UHFFFAOYSA-N 0.000 description 5
- 241000736873 Tetraclinis articulata Species 0.000 description 3
- 150000007513 acids Chemical class 0.000 description 3
- 229920003086 cellulose ether Polymers 0.000 description 3
- 235000019441 ethanol Nutrition 0.000 description 3
- 150000002170 ethers Chemical class 0.000 description 3
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 3
- 229960004592 isopropanol Drugs 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 239000006187 pill Substances 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 230000028327 secretion Effects 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- 210000001685 thyroid gland Anatomy 0.000 description 3
- ZNQVEEAIQZEUHB-UHFFFAOYSA-N 2-ethoxyethanol Chemical compound CCOCCO ZNQVEEAIQZEUHB-UHFFFAOYSA-N 0.000 description 2
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- 239000001856 Ethyl cellulose Substances 0.000 description 2
- ZZSNKZQZMQGXPY-UHFFFAOYSA-N Ethyl cellulose Chemical compound CCOCC1OC(OC)C(OCC)C(OCC)C1OC1C(O)C(O)C(OC)C(CO)O1 ZZSNKZQZMQGXPY-UHFFFAOYSA-N 0.000 description 2
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 2
- 150000008065 acid anhydrides Chemical class 0.000 description 2
- 150000008064 anhydrides Chemical class 0.000 description 2
- 125000002843 carboxylic acid group Chemical group 0.000 description 2
- 239000000969 carrier Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229920001249 ethyl cellulose Polymers 0.000 description 2
- 235000019325 ethyl cellulose Nutrition 0.000 description 2
- 210000004907 gland Anatomy 0.000 description 2
- 125000001557 phthalyl group Chemical group C(=O)(O)C1=C(C(=O)*)C=CC=C1 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 239000011343 solid material Substances 0.000 description 2
- 239000000454 talc Substances 0.000 description 2
- 229910052623 talc Inorganic materials 0.000 description 2
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 2
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 1
- DHKVCYCWBUNNQH-UHFFFAOYSA-N 2-[5-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]-1,3,4-oxadiazol-2-yl]-1-(1,4,5,7-tetrahydropyrazolo[3,4-c]pyridin-6-yl)ethanone Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)C1=NN=C(O1)CC(=O)N1CC2=C(CC1)C=NN2 DHKVCYCWBUNNQH-UHFFFAOYSA-N 0.000 description 1
- 235000007173 Abies balsamea Nutrition 0.000 description 1
- 229920001342 Bakelite® Polymers 0.000 description 1
- 239000004857 Balsam Substances 0.000 description 1
- 240000005209 Canarium indicum Species 0.000 description 1
- 229920008347 Cellulose acetate propionate Polymers 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 244000018716 Impatiens biflora Species 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- VCUFZILGIRCDQQ-KRWDZBQOSA-N N-[[(5S)-2-oxo-3-(2-oxo-3H-1,3-benzoxazol-6-yl)-1,3-oxazolidin-5-yl]methyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C1O[C@H](CN1C1=CC2=C(NC(O2)=O)C=C1)CNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F VCUFZILGIRCDQQ-KRWDZBQOSA-N 0.000 description 1
- 240000005428 Pistacia lentiscus Species 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 1
- 240000008548 Shorea javanica Species 0.000 description 1
- UGZICOVULPINFH-UHFFFAOYSA-N acetic acid;butanoic acid Chemical compound CC(O)=O.CCCC(O)=O UGZICOVULPINFH-UHFFFAOYSA-N 0.000 description 1
- AVMNFQHJOOYCAP-UHFFFAOYSA-N acetic acid;propanoic acid Chemical compound CC(O)=O.CCC(O)=O AVMNFQHJOOYCAP-UHFFFAOYSA-N 0.000 description 1
- 230000009858 acid secretion Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 239000004637 bakelite Substances 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 229920002301 cellulose acetate Polymers 0.000 description 1
- 229920006217 cellulose acetate butyrate Polymers 0.000 description 1
- 229920006218 cellulose propionate Polymers 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 239000007891 compressed tablet Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 238000010410 dusting Methods 0.000 description 1
- 239000004862 elemi Substances 0.000 description 1
- 239000002662 enteric coated tablet Substances 0.000 description 1
- 125000001033 ether group Chemical group 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000416 exudates and transudate Anatomy 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- SLGWESQGEUXWJQ-UHFFFAOYSA-N formaldehyde;phenol Chemical compound O=C.OC1=CC=CC=C1 SLGWESQGEUXWJQ-UHFFFAOYSA-N 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 239000007903 gelatin capsule Substances 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 210000002011 intestinal secretion Anatomy 0.000 description 1
- 239000013521 mastic Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 150000007530 organic bases Chemical class 0.000 description 1
- 230000002611 ovarian Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 229920001568 phenolic resin Polymers 0.000 description 1
- XNGIFLGASWRNHJ-UHFFFAOYSA-L phthalate(2-) Chemical compound [O-]C(=O)C1=CC=CC=C1C([O-])=O XNGIFLGASWRNHJ-UHFFFAOYSA-L 0.000 description 1
- -1 phthalic acid Chemical class 0.000 description 1
- KQOCPYKMLMTOOP-UHFFFAOYSA-N phthalic acid;propanoic acid Chemical compound CCC(O)=O.OC(=O)C1=CC=CC=C1C(O)=O KQOCPYKMLMTOOP-UHFFFAOYSA-N 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 150000007519 polyprotic acids Polymers 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 150000003873 salicylate salts Chemical class 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-L succinate(2-) Chemical compound [O-]C(=O)CCC([O-])=O KDYFGRWQOYBRFD-UHFFFAOYSA-L 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/282—Organic compounds, e.g. fats
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
Definitions
- This invention has for its object to provide an enterlo coating which does not break down in the stomach, but which disintegrates and completely releases the imprisoned powder or pill or the like when it reaches the intestines and which possesses the unique property whenin the liquid state, prior to its application and subsequent drying, that it can be rapidly and eiiiciently applied and will quickly dry to give a coating consisting of a very large content of solid material, thereby greatly decreasing the number of times that the liquid preparation must be applied in order to obtain a satisfactory final coating upon drying.
- Another object of the invention is to provide liquid enteric coating compound which is exceptionally valuable and efiicient in the process of applying a coating to a medicament and which works well in the rotating pans ordinarily used for this purpose.
- liquid cellulose derivative compositions require a great many separate applications to the medicament in order to build up a satisfactory dry coating of sufllcient thickness. It is quite important that the liquid be applied a sufiicient number of times, with adequate drying between coats, since the i'lnal dry enteric coating. must be of such thickness that the stomach secretions do not penetrate the same during the considerable period of time in which the coated tablet. or pill normally remains in the stomach.
- cellulose esters of polycarboxylic acids containing free unesterifled carboxylic acid groups can be combined in certain proportions with a lac, or resinous plant or insect exudate, of the type of shellac and the combination dissolved or taken up in a common solvent to give liquid preparations of exceptional value in the process of applying a coating quickly and that enteric coatings consisting of shellac, when made thick enough to stand up in the stomach, do not dissolve as rapidly or as completely in the intestines as they ought to forthe proper release of medicament.
- My new coatings are definitely superior to straight shellac coatings in this respect.
- cellulose derivatives containing free carboxyl groups any of those made by known methods of preparation, such as those disclosed in United States Patents Nos. 2,093,462,and 2,093,464 and also 2,126,460.
- cellulose or its derivative containing free hydroxyls canbe reacted with a polycarboxylic acid acylating agent, such as an anhydride of the polycarboxylic acid in the presence of a base, or in the presence of a solvent and in the absence of an organic base.
- the esters of cellulose may be simple esters of polycarboxylic acids or may be mixed esters wherein more than one kind ofpolycarboxylic acid group is present. They may be also esters of such acids which also contain cellulose ether groups of the mixed etherester type.
- I may use the reaction products of polycarboxylic acid anhydrides with cellulose or its esters or ethers or ether-esters containing free hydroxyls capable of combining with the acid anhydride to form an ester linkage and also leaving free carare, for example, phthalic, succinic and maleio anhydrides.
- cellulose derivatives which may be acylated are cellulose acetate, propionate, acetate-propionate, acetate-butyrate, and ethers of cellulose such as ethyl cellulose, benzyl cellulose, etc., containing free hydroxyls in the cellulose part of the ester.
- Free carboxyl need not be present in molecular proportions but the ester, including the ether-esters, may have any free carboxyl content from only a few percent up to about 25%. A free carboxyl content between about and has been found to be the most preferable.
- any of the known inert organic solvents for such esters may be used, providing the solution of ester will also hold in solution considerable quantities of lac of shellac.
- I may use acetone, methyl ethyl ketone, isopropyl alcohol, combinations of these such as acetone with ethyl alcohol and, in general, any suitable volatile common solvent or solvent combination for the lac or resin and the cellulose derivatives.
- Suitable solvents can readily be ascertained by simple experiment. For example, the cellulose ester is thoroughly mixed with the solvent, either with or without heating, until it is dissolved. The plant lac or resin is then worked or triturated gradually in its solid form into the solution of ester.
- a solution of the lac in the same or a similar solvent may be mixed with the solution of ester.
- any combinations having a tendency to throw out ester or lac, or both can be noted. Thereby, one can readily determine the safe limits of concentration and begins to lose its uniformity.
- the solvent should not be too volatile, since the period of fluidity of .the'mixture would be shortened so that the coating would not then be uniformly distributed over each tablet before the solvent has evaporated.
- resins, lacs or gums which I use in my preparations are referred to herein and in the appended claims as resinous carriers for the cellulose derivatives and may be any of the known compositions of this type, of naturalor synthetic origin, which are therapeutically innocuous and insoluble in acid but soluble in the alkaline medium of the intestines.
- resinous carriers for the cellulose derivatives which I use are elemi, mastic and sandarac gums, damar, tolu and shellac, resins, rosin, hydrogenated rosins, soluble Bakelite resins (phenol-formaldehyde type resin) and other synthetic resinous condensates and polymers soluble in the volatile organic solvents mens 4 10% to 50% of the acetate-phthalate are satisfactory.
- Example 1 10 lbs. of bleached shellac are dissolved in 2 /2 gallons of denatured ethyl alcohol (U. S. Government formula 3A). Another solution is made by dissolving 5 lbs. of cellulose acetatephthalate in 3 gallons of acetone. The two solutions are then mixed together slowly with stirring. The resulting liquid preparation is excellently suited to use in coating medicaments, such as tablets, because it is of a mucilaginous character, pours somewhat like castor oil and is sufficiently fluid that it spreads over the tablets and coats them uniformly. It has a viscosity of 250 Say-bolt seconds at 30 C.
- Example 2 The liquid preparation of Example 1 is poured over 2 grain compressed tablets containing 1 grain of desiccated thyroid gland and having been previously given a thin sub-coat of acacia mucilage and then dusted with calcium carbonate or talc. During the pouring of the coating liquid, the tablets are rolled about and agitated in the customary manner in a rotating drumlike pan provided with a drying air duct. For example, about 100,000 of these 2 grain tablets can be given a single dose coating by pouring onto them during agitation 1% to 2 pints of the liquid preparation. The liquid can be applied in a few seconds and the tablets are uniformly coated and begin to get tacky in only one minute or even less. At this time talc or similar dusting powder is added in suflicient quantity to prevent the tablets from sticking to each other or to the pan.
- dusted tablets need only /2 hour of further rolling and drying in the pan until they are ready for another coating which is applied in the same manner.
- Example 3 10 lbs. of balsam tolu are dissolved in 10 pints of acetone. Another solution is made up by dissolving 4 lbs, of cellulose acetate-phthalate in 2 /2 gallons of isopropylalcohol. The two solutions are slowly mixed. The coating liquid so obtained is applied as described in Example 2 to tablets of desiccated ovarian tissue. The liquid goes onto the tablets readily and uniformly and the dry coated tablets carry an efiicient enteric coating.
- Example 4 5 lbs. of cellulose acetate-phthalate and lbs. of bleached shellac are dissolved in 2 /2 gallons of Cellosolve (ethylene glycol monoethyl ether). This liquid combination can be applied to gland tablets, in the manner already described or by any of the known coating methods.
- Cellosolve ethylene glycol monoethyl ether
- Example 5 25 lbs. of cellulose propionate-phthalate and 50 lbs. of hydrogenated rosin are dissolved in gallons of dioxane to give a liquid preparation suitable for application as an enteric coating to powdered gland products, crystalline substances such as ammonium chloride, sodium iodide, salicylate salts, etc.
- Example 6 12 lbs. of gum sandarac are dissolved in 3 gal- Ions of isopropanol. A second solution of 2% lbs. of ethyl cellulose phthalate or succinate in 10 pints of methyl ethyl ketone is prepared and carefully mixed with the sandarac solution.
- This provides a coating liquid which applies to solid materials easily and quickly and dries to an enteric coating that functions ideally in the alimentary tract. For example, this liquid can be applied to medicaments encapsulated within the ordinary telescoping gelatin capsules as well as to pills and tablets.
- cellulose ester compound physiologically relatively inactive resinous carrier and solvent which have a viscosity between about 200 Saybolt seconds and about 500 Saybolt seconds at room temperature.
- shellac it is preferred to use more shellac than cellulose ester because such proportions give the best combination of properties for the coating solutions.
- An enteric coated substance for use by oral ingestion said substance being surrounded by an enteric film of a cellulose ester derivative containing free carboxyl groups incorporated in a resinous carrier for said derivative and which film is insoluble in the stomach but soluble in the intestines.
- a solution for the application of enteric coatings consisting of a cellulose ester derivative containing free carboxyl groups and a resinous carrier therefor in solution in an inert volatile common organic solvent for said ester derivative and carrier.
- An enteric coated substance for use by oral ingestion said substance being surrounded by an enteric film of a cellulose ester derivative containing free carboxyl groups incorporated in shellac and which film isinsoluble in the stomach but soluble in the intestines.
- a solution for the application of enteric coatings consisting of a cellulose ester derivative containing free carboxyl groups and shellac in solution in an inert volatile common organic solvent for said ester derivative and shellac.
- a solution for the application of enteric coatings consisting of a cellulose ester derivative containing free carboxyl groups and shellac in solution in a mixture of acetone and alcohol having a viscosity at room temperature between about 200 Saybolt seconds and 500 Saybolt seconds.
- a solution for the application of enteric coatings consisting of cellulose acetate-phthalate containing free carboxyl groups and shellac in an inert volatile common organic solvent for said acetate-phthalate and shellac.
- a solution for the application of enteric coatings consisting of a lower fatty acid-partial phthalic acid mixed ester of cellulose, containing free carboxyl, and shellac in solution in an inert volatile common organic solvent for said mixed ester and shellac, having a viscosity at room temperature between about 200 Saybolt seconds and 500 Saybolt seconds.
- a solution for the application of enteric coatings consisting of cellulose acetate-phthalate, containing about 33% phthalyl, and shellac in solution in an inert volatile common organic solvent, said acetate-phthalate and shellac being present in proportions within the ranges of about 10 to 50% acetate-phthalate and 50-90% shellac, said solution having a viscosity between about 200 Saybolt seconds and 500 Saybolt seconds.
- An enteric coated substance for use by oral ingestion said substance being surrounded by an enteric film of a lower fatty acid-partial phthalic acid mixed ester of cellulose containing free carboxyl groups incorporated in a resinous carrier for said ester and which film is insoluble in the stomach but soluble in the intestines.
- An enteric coated substance for use by oral ingestion said substance being surrounded by an enteric film of a lower fatty acid-partial phthalic acid mixed ester of cellulose containing free carboxyl groups incoporated in shellac, said film being insoluble in the stomach but soluble in the intestines.
- An enteric coated substance for use by oral ingestion said substance being surrounded by an enteric film of shellac and cellulose-acetatephthalate, containing about 33% phthalyl, said acetate-phthalate and shellac being present in proportions within the ranges of about 10-50% cellulose acetate-phthalate and 50-90% shellac.
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
Description
Patented Dec. 23, 1947 ENTERIC COATING Thurston Reese Springctt, Grosse Pointe Park, Mich., assignor to Parke, Davis & Company, Detroit, Mich.,' a corporation of Michigan No Drawing. Application August 28, 1944,
Serial No. 551,631
11 Claims.
. l The invention relates to compositions for use in coating medicaments and like materials for oral ingestion with a layer or film which is substantially soluble in, Or disintegrated by, the intestinal secretions but which is substantially insoluble in the acid secretions of the stomach.
Numerous substances have been proposed for the purpose of applying and drying an enteric coating or film onto medicaments, powders, tablets and the like.
However, none of them combine all the advantages of resisting penetration of the coating by the stomach secretions during the period of time in which the coated products are normally in contact with such secretions, while at the same time breaking up and releasing medicament with sufllcient rapidity in the intestinal tract, and having the property in the liquid state that the coating can be rapidly and efilciently applied in commerclalpractice.
This invention has for its object to provide an enterlo coating which does not break down in the stomach, but which disintegrates and completely releases the imprisoned powder or pill or the like when it reaches the intestines and which possesses the unique property whenin the liquid state, prior to its application and subsequent drying, that it can be rapidly and eiiiciently applied and will quickly dry to give a coating consisting of a very large content of solid material, thereby greatly decreasing the number of times that the liquid preparation must be applied in order to obtain a satisfactory final coating upon drying. Another object of the invention is to provide liquid enteric coating compound which is exceptionally valuable and efiicient in the process of applying a coating to a medicament and which works well in the rotating pans ordinarily used for this purpose.
Heretofore it has been proposed to use cellulose esters and cellulose ethers containing free carboxylgroups; I have found that such esters or mixtures (if-esters and ethers, when made up in organic solvent and poured, or sprayed, or otherwise coated onto medicaments, result in enteric coatings which are'to a certain extent satisfactory from the standpoint that they may pass through the stomach without'disintegrating and will break up upon reaching the intestines. How- 'ever, I have found that they are totally unsatisfactory for a commercial coating process, due to the fact that they must be highly diluted by solvent in order to give preparations which can be quickly and uniformly applied in the usual large scale commercial coating methods. These known liquid cellulose derivative compositions require a great many separate applications to the medicament in order to build up a satisfactory dry coating of sufllcient thickness. It is quite important that the liquid be applied a sufiicient number of times, with adequate drying between coats, since the i'lnal dry enteric coating. must be of such thickness that the stomach secretions do not penetrate the same during the considerable period of time in which the coated tablet. or pill normally remains in the stomach.
I have now found that cellulose esters of polycarboxylic acids containing free unesterifled carboxylic acid groups can be combined in certain proportions with a lac, or resinous plant or insect exudate, of the type of shellac and the combination dissolved or taken up in a common solvent to give liquid preparations of exceptional value in the process of applying a coating quickly and that enteric coatings consisting of shellac, when made thick enough to stand up in the stomach, do not dissolve as rapidly or as completely in the intestines as they ought to forthe proper release of medicament. My new coatings are definitely superior to straight shellac coatings in this respect.
In carrying out my invention, I may use, as cellulose derivatives containing free carboxyl groups, any of those made by known methods of preparation, such as those disclosed in United States Patents Nos. 2,093,462,and 2,093,464 and also 2,126,460. For example, cellulose or its derivative containing free hydroxyls canbe reacted with a polycarboxylic acid acylating agent, such as an anhydride of the polycarboxylic acid in the presence of a base, or in the presence of a solvent and in the absence of an organic base. The esters of cellulose may be simple esters of polycarboxylic acids or may be mixed esters wherein more than one kind ofpolycarboxylic acid group is present. They may be also esters of such acids which also contain cellulose ether groups of the mixed etherester type. I
I may use the reaction products of polycarboxylic acid anhydrides with cellulose or its esters or ethers or ether-esters containing free hydroxyls capable of combining with the acid anhydride to form an ester linkage and also leaving free carare, for example, phthalic, succinic and maleio anhydrides. Examples of cellulose derivatives which may be acylated are cellulose acetate, propionate, acetate-propionate, acetate-butyrate, and ethers of cellulose such as ethyl cellulose, benzyl cellulose, etc., containing free hydroxyls in the cellulose part of the ester.
I prefer to use non-toxic mixed cellulose esters of lower monobasic fatty acids and a polybasic acid, such as phthalic acid, with at least one free unesterified 'carboxylic acid group, e. g., celluloseacetate-propionate-phthalate and the like. Free carboxyl need not be present in molecular proportions but the ester, including the ether-esters, may have any free carboxyl content from only a few percent up to about 25%. A free carboxyl content between about and has been found to be the most preferable.
As solvents for the cellulose esters containing free carboxyl groups, any of the known inert organic solvents for such esters may be used, providing the solution of ester will also hold in solution considerable quantities of lac of shellac. I may use acetone, methyl ethyl ketone, isopropyl alcohol, combinations of these such as acetone with ethyl alcohol and, in general, any suitable volatile common solvent or solvent combination for the lac or resin and the cellulose derivatives. Suitable solvents can readily be ascertained by simple experiment. For example, the cellulose ester is thoroughly mixed with the solvent, either with or without heating, until it is dissolved. The plant lac or resin is then worked or triturated gradually in its solid form into the solution of ester. Alternatively, a solution of the lac in the same or a similar solvent may be mixed with the solution of ester. By varying the proportions of solvents and dissolved materials, any combinations having a tendency to throw out ester or lac, or both can be noted. Thereby, one can readily determine the safe limits of concentration and begins to lose its uniformity. On the other hand, the solvent should not be too volatile, since the period of fluidity of .the'mixture would be shortened so that the coating would not then be uniformly distributed over each tablet before the solvent has evaporated.
The resins, lacs or gums which I use in my preparations are referred to herein and in the appended claims as resinous carriers for the cellulose derivatives and may be any of the known compositions of this type, of naturalor synthetic origin, which are therapeutically innocuous and insoluble in acid but soluble in the alkaline medium of the intestines.
Examples of these resinous carriers for the cellulose derivatives which I use are elemi, mastic and sandarac gums, damar, tolu and shellac, resins, rosin, hydrogenated rosins, soluble Bakelite resins (phenol-formaldehyde type resin) and other synthetic resinous condensates and polymers soluble in the volatile organic solvents mens 4 10% to 50% of the acetate-phthalate are satisfactory.
The invention can be illustrated by the following examples:
Example 1 10 lbs. of bleached shellac are dissolved in 2 /2 gallons of denatured ethyl alcohol (U. S. Government formula 3A). Another solution is made by dissolving 5 lbs. of cellulose acetatephthalate in 3 gallons of acetone. The two solutions are then mixed together slowly with stirring. The resulting liquid preparation is excellently suited to use in coating medicaments, such as tablets, because it is of a mucilaginous character, pours somewhat like castor oil and is sufficiently fluid that it spreads over the tablets and coats them uniformly. It has a viscosity of 250 Say-bolt seconds at 30 C.
Example 2 The liquid preparation of Example 1 is poured over 2 grain compressed tablets containing 1 grain of desiccated thyroid gland and having been previously given a thin sub-coat of acacia mucilage and then dusted with calcium carbonate or talc. During the pouring of the coating liquid, the tablets are rolled about and agitated in the customary manner in a rotating drumlike pan provided with a drying air duct. For example, about 100,000 of these 2 grain tablets can be given a single dose coating by pouring onto them during agitation 1% to 2 pints of the liquid preparation. The liquid can be applied in a few seconds and the tablets are uniformly coated and begin to get tacky in only one minute or even less. At this time talc or similar dusting powder is added in suflicient quantity to prevent the tablets from sticking to each other or to the pan.
The dusted tablets need only /2 hour of further rolling and drying in the pan until they are ready for another coating which is applied in the same manner.
By repeating the coatings until a total of four or five coats have been applied, one obtains enteric coated tablets of thyroid gland which do not break up in the stomach but which disintegrate readily and completely in the intestines. Approximately two hours is all the time needed to get these final enteric coated thyroid tablets when using my new liquid preparations. On the other hand, when using this kind of alcoholacetone solution of cellulose acetate-phthalate in the absence of any resinous carrier such as shellac, the total time required to get a satisfactory enteric coating is upwards of 12 hours and much more labor is needed, since 20 or 30 separate applications, with intermediate drying periods, must be put on the tablets. Moreover, a coating which does not contain the resinous carrier very frequently ruins the entire batch .of tablets, because irregularities form on the inner lining of the pan during drying and these bring about formation of so-called crumbs, bumps and like irregularities in the surface of the individual tablets. Such irregularities destroy the effectiveness of the coating and render the tablets unsightly and umnarketable.
Example 3 10 lbs. of balsam tolu are dissolved in 10 pints of acetone. Another solution is made up by dissolving 4 lbs, of cellulose acetate-phthalate in 2 /2 gallons of isopropylalcohol. The two solutions are slowly mixed. The coating liquid so obtained is applied as described in Example 2 to tablets of desiccated ovarian tissue. The liquid goes onto the tablets readily and uniformly and the dry coated tablets carry an efiicient enteric coating.
Example 4 5 lbs. of cellulose acetate-phthalate and lbs. of bleached shellac are dissolved in 2 /2 gallons of Cellosolve (ethylene glycol monoethyl ether). This liquid combination can be applied to gland tablets, in the manner already described or by any of the known coating methods.
Example 5 25 lbs. of cellulose propionate-phthalate and 50 lbs. of hydrogenated rosin are dissolved in gallons of dioxane to give a liquid preparation suitable for application as an enteric coating to powdered gland products, crystalline substances such as ammonium chloride, sodium iodide, salicylate salts, etc.
Example 6 12 lbs. of gum sandarac are dissolved in 3 gal- Ions of isopropanol. A second solution of 2% lbs. of ethyl cellulose phthalate or succinate in 10 pints of methyl ethyl ketone is prepared and carefully mixed with the sandarac solution. This provides a coating liquid which applies to solid materials easily and quickly and dries to an enteric coating that functions ideally in the alimentary tract. For example, this liquid can be applied to medicaments encapsulated within the ordinary telescoping gelatin capsules as well as to pills and tablets.
The above examples are intended for illustration and the invention is not to be limited to the specific compositions, materials and conditions specified therein. Numerous equivalents and variations, over and above what is shown in the examples, are possible within the scope of the invention.
In general, I prefer combinations of cellulose ester compound, physiologically relatively inactive resinous carrier and solvent which have a viscosity between about 200 Saybolt seconds and about 500 Saybolt seconds at room temperature. When using shellac as the resinous carrier, it is preferred to use more shellac than cellulose ester because such proportions give the best combination of properties for the coating solutions.
What I claim as my invention is:
1. An enteric coated substance for use by oral ingestion, said substance being surrounded by an enteric film of a cellulose ester derivative containing free carboxyl groups incorporated in a resinous carrier for said derivative and which film is insoluble in the stomach but soluble in the intestines.
2. A solution for the application of enteric coatings consisting of a cellulose ester derivative containing free carboxyl groups and a resinous carrier therefor in solution in an inert volatile common organic solvent for said ester derivative and carrier.
3. An enteric coated substance for use by oral ingestion, said substance being surrounded by an enteric film of a cellulose ester derivative containing free carboxyl groups incorporated in shellac and which film isinsoluble in the stomach but soluble in the intestines.
4. A solution for the application of enteric coatings consisting of a cellulose ester derivative containing free carboxyl groups and shellac in solution in an inert volatile common organic solvent for said ester derivative and shellac.
5. A solution for the application of enteric coatings consisting of a cellulose ester derivative containing free carboxyl groups and shellac in solution in a mixture of acetone and alcohol having a viscosity at room temperature between about 200 Saybolt seconds and 500 Saybolt seconds.
6. A solution for the application of enteric coatings consisting of cellulose acetate-phthalate containing free carboxyl groups and shellac in an inert volatile common organic solvent for said acetate-phthalate and shellac.
'7. A solution for the application of enteric coatings consisting of a lower fatty acid-partial phthalic acid mixed ester of cellulose, containing free carboxyl, and shellac in solution in an inert volatile common organic solvent for said mixed ester and shellac, having a viscosity at room temperature between about 200 Saybolt seconds and 500 Saybolt seconds.
8. A solution for the application of enteric coatings consisting of cellulose acetate-phthalate, containing about 33% phthalyl, and shellac in solution in an inert volatile common organic solvent, said acetate-phthalate and shellac being present in proportions within the ranges of about 10 to 50% acetate-phthalate and 50-90% shellac, said solution having a viscosity between about 200 Saybolt seconds and 500 Saybolt seconds.
9. An enteric coated substance for use by oral ingestion, said substance being surrounded by an enteric film of a lower fatty acid-partial phthalic acid mixed ester of cellulose containing free carboxyl groups incorporated in a resinous carrier for said ester and which film is insoluble in the stomach but soluble in the intestines.
10. An enteric coated substance for use by oral ingestion, said substance being surrounded by an enteric film of a lower fatty acid-partial phthalic acid mixed ester of cellulose containing free carboxyl groups incoporated in shellac, said film being insoluble in the stomach but soluble in the intestines.
11. An enteric coated substance for use by oral ingestion, said substance being surrounded by an enteric film of shellac and cellulose-acetatephthalate, containing about 33% phthalyl, said acetate-phthalate and shellac being present in proportions within the ranges of about 10-50% cellulose acetate-phthalate and 50-90% shellac.
THURSTON REESE SPRINGE'I'I.
REFERENCES CITED The following references are of record in the file of this patent:
UNITED STATES PATENTS Name Date Hiatt Apr. 9, 1940 OTHER REFERENCES Number
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US551631A US2433244A (en) | 1944-08-28 | 1944-08-28 | Enteric coating |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US551631A US2433244A (en) | 1944-08-28 | 1944-08-28 | Enteric coating |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| US2433244A true US2433244A (en) | 1947-12-23 |
Family
ID=24202060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| US551631A Expired - Lifetime US2433244A (en) | 1944-08-28 | 1944-08-28 | Enteric coating |
Country Status (1)
| Country | Link |
|---|---|
| US (1) | US2433244A (en) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3015610A (en) * | 1957-11-04 | 1962-01-02 | Jr Roy Y Sanders | Marked pharmaceutical tablet |
| US3477864A (en) * | 1965-05-07 | 1969-11-11 | Sumitomo Chemical Co | Process for coating pharmaceutical preparations with a hydroxy propyl methyl cellulose-sealing agent moisture-preventing film |
| US4147768A (en) * | 1976-09-13 | 1979-04-03 | Interx Research Corporation | Enteric coated digoxin and therapeutic use thereof |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2196768A (en) * | 1938-03-11 | 1940-04-09 | Eastman Kodak Co | Enteric coating |
-
1944
- 1944-08-28 US US551631A patent/US2433244A/en not_active Expired - Lifetime
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2196768A (en) * | 1938-03-11 | 1940-04-09 | Eastman Kodak Co | Enteric coating |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3015610A (en) * | 1957-11-04 | 1962-01-02 | Jr Roy Y Sanders | Marked pharmaceutical tablet |
| US3477864A (en) * | 1965-05-07 | 1969-11-11 | Sumitomo Chemical Co | Process for coating pharmaceutical preparations with a hydroxy propyl methyl cellulose-sealing agent moisture-preventing film |
| US4147768A (en) * | 1976-09-13 | 1979-04-03 | Interx Research Corporation | Enteric coated digoxin and therapeutic use thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US2921883A (en) | Novel coating material for medicaments | |
| US2196768A (en) | Enteric coating | |
| US4816259A (en) | Process for coating gelatin capsules | |
| US2887440A (en) | Enteric coating | |
| US3576663A (en) | Coated tablet | |
| US4377568A (en) | Preparation of aqueous alcoholic dispersions of pH sensitive polymers and plasticizing agents and a method of enteric coating dosage forms using same | |
| US3789117A (en) | Process for the preparation of enteric medicaments | |
| WO2004030658A1 (en) | Enteric composition for the manufacture of soft capsule wall | |
| US3592945A (en) | Soft-gelatine capsules with increased heat resistance and method of their production | |
| JPH0258246B2 (en) | ||
| EP0023327B1 (en) | Sugar-coated tablet containing fat-soluble pharmaceutical material | |
| US2491475A (en) | Enteric capsule | |
| KR930001277B1 (en) | Process for preparing pancreatic enzyme products | |
| US3524756A (en) | Process of coating tablets with alternate tacky and non-tacky layers | |
| US3449489A (en) | Pharmaceutical compositions and their preparation | |
| US2433244A (en) | Enteric coating | |
| US2798024A (en) | Composite enteric tablet of erythromycin and sulfonamides | |
| US5015480A (en) | Film coating formulations | |
| US2993837A (en) | Enteric coated tablets | |
| US2390088A (en) | Enteric gelatin capsule shell or envelope | |
| US2816061A (en) | Sodium carboxymethyl cellulose tablet coating | |
| US2897122A (en) | Enteric coated product | |
| US2853421A (en) | Gelatin pan coating | |
| US3476588A (en) | Process for coating tablets | |
| GB760403A (en) | Improvements in or relating to enteric coatings |